ʻO Rivaroxaban 366789-02-8 Ke mālama nei ke koko i ka Antithrombosis
Uku:T/T, L/C
Kumu Huahana:Kina
Awa moku:Pekina/Shanghai/Hangzhou
Hiki ke hana:200kg / mahina
Kauoha(MOQ):25 kg
Ka manawa o waena o ka hoʻomaka a i ka wā pau:3 Nā lā hana
Kūlana mālama:Hoʻopaʻa ʻia ma kahi anuanu, maloʻo, ka lumi wela.
Mea paʻa:pahu
Nui pūʻolo:25kg / pahu
ʻIke palekana:ʻAʻole nā mea weliweli
Hoʻolauna
ʻO Rivaroxaban, he lāʻau anticoagulant (hoʻemi koko).Hoʻohana ia i nā poʻe mākua me ka fibrillation atrial nonvalvular (koe wale ka fibrillation atrial ma muli o ka maʻi puʻuwai rheumatic valvular, a me ka fibrillation atrial ma hope o ka hoʻololi ʻana i ka puʻuwai puʻuwai) e hōʻemi i ka pilikia o ka hahau a me ka systemic embolism.
Hoʻohana ʻia ʻo Rivaroxaban e mālama a pale i nā ʻōpū koko.
Hoʻohana ʻia ʻo Rivaroxaban f no nā poʻe maʻi makua e hoʻopaʻa ana i ka ʻūhā a i ʻole ke kuli pani e pale ai i ka thrombosis venous.
Hōʻike (EP)
| 'ikamu | Hōʻike |
| Ka nana aku | Pauda keʻokeʻo a melemele paha |
| Ka hoʻoheheʻe | ʻAʻole hiki ke hoʻoheheʻe ʻia i loko o ka wai, hiki ke hoʻoheheʻe ʻia i DMSO, hiki ʻole ke hoʻoheheʻe ʻia i ka ethanol anhydrous a me ka heptanes. |
| ʻIkepili | IR: Pono ka Spectrum e hoʻokō i ka WS |
| Pono e hoʻokō ka HPLC-RT o ka laʻana ma lalo o ka hoʻomaʻemaʻe enantiometric me ka WS. | |
| Wai | ≤0.5% |
| Lehu sulfate | ≤0.1% |
| Pohō ma ka maloʻo | ≤0.5% |
| Nā metala kaumaha | ≤20ppm |
| Enantionmer | haumia A: ≤0.4% |
| Ke koena solvent | Ethanol: ≤5000ppm Ethyl acetate: ≤5000ppm Acetone: ≤5000ppm N, N-Dimethylformamide: ≤880ppm Methylene chloride: ≤600ppm Benzene: ≤2ppm |
| Mea pili | haumia B: ≤0.10% haumia D: ≤0.10% haumia E: ≤0.10% haumia F: ≤0.10% haumia G: ≤0.10% haumia H: ≤0.10% haumia I: ≤0.10% haumia J: ≤0.10% RVB-4-NJSH: ≤0.10% RVB-ZA: ≤0.10% RVB-BAM: ≤0.10% RVB-ZC: ≤0.10% RVB-HBY: ≤75ppm ʻO nā mea haumia ʻē aʻe i ʻike ʻole ʻia: ≤0.10% Huina haumia: ≤0.3% |
| Ka hāʻawi ʻana i ka nui o nā ʻāpana | D10:/ D50:/ D90:/ |
| Hoʻāʻo (mea anhydrous) | 98.0-102.0 |
